Company's Profile
Clarity Pharmaceuticals Ltd is an Australian clinical-stage radiopharmaceutical company specializing in theranostic (therapy and imaging) products. They utilize their SAR Technology platform to develop innovative solutions for diagnosing, staging, and treating various types of cancers. Their three key products are SARTATE (targeting SSTR2-expressing cancers like neuroblastoma and neuroendocrine tumors), SAR-bisPSMA (targeting PSMA-expressing cancers, particularly prostate cancer), and SAR-Bombesin (used to identify and select patients for subsequent treatment of GRPr-expressing cancers like breast and prostate cancer). Clarity Pharmaceuticals is actively involved in multiple clinical trials, addressing both common and rare/orphan indications of cancer.
